Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health
Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identifi...
Gespeichert in:
Veröffentlicht in: | Vascular pharmacology 2021-06, Vol.138, p.106838-106838, Article 106838 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 106838 |
---|---|
container_issue | |
container_start_page | 106838 |
container_title | Vascular pharmacology |
container_volume | 138 |
creator | Kumar, R.K. Kaiser, L.M. Rockwell, C.E. Watts, S.W. |
description | Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identified as one of the highly expressed (mRNA) cytokines in the mesenteric PVAT of healthy rats. One report suggested that exogenous IL-10 causes relaxation of mouse mesenteric arteries, also suggesting that IL-10 maybe a potential anti-contractile factor. Hence, we hypothesized that PVAT-derived IL-10 causes vasorelaxation and/or reduces vasoconstriction, thus contributing to the anti-contractile nature of PVAT in health. Mesenteric arteries from rats and mice expressed the receptor for IL-10 (in tunica intima and media) as determined by immunohistochemistry. Mesenteric resistance arteries for rats and superior mesenteric artery for mice were used for isometric contractility studies. Increasing concentrations [0.4–100 ng/mL] of recombinant rat/mouse (rr/mr) IL-10 or vehicle was directly added to half-maximally constricted (phenylephrine, PE) vessels (without PVAT, with endothelium). IL-10 did not cause a direct vasorelaxation. Further, the ability of rrIL-10 to cause a rightward or downward shift of a vasoconstriction-response curve was tested in the rat. The vessels were incubated with rrIL-10 [100 ng/mL or 10 ng/mL] or vehicle for 1.5 h in the tissue bath followed by a cumulative PE [10−8–10−4 M] or U46619 [10−10–10−5 M] response curve. The maximal contractions and EC50 values were similar in IL-10 incubated vessels vs vehicle. Thus, acute exposure of exogenous IL-10 did not reduce local vasoconstriction. To further test if endogenous IL-10 from PVAT was anti-contractile, superior mesenteric arteries from IL-10 WT and KO mice, with and without PVAT, were subjected to increasing concentrations of PE. The anti-contractile nature of PVAT was preserved with both short-term and prolonged depletion (using younger and older mice, respectively) of endogenous IL-10 in males and females. Contrary to our hypothesis, PVAT-derived IL-10 neither caused vasorelaxation nor reduced local vasoconstriction directly/indirectly. Therefore, IL-10 does not contribute to the anti-contractile nature of PVAT in healthy rodents.
[Display omitted]
•IL-10 (mRNA) was expressed in mesenteric PVATs of rats and mice in health.•IL-10 receptor was present in the mesenteric arteries of both rats and |
doi_str_mv | 10.1016/j.vph.2021.106838 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8174099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1537189121000100</els_id><sourcerecordid>2539557981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-ae2520a7a59312f417962fdc7590e861bc5aca43f7e447a245ee76b5852acf2f3</originalsourceid><addsrcrecordid>eNp9UV1LHDEUDaVSP9of0JcS6POs-ZwkFAoirQqCgravIZu508l2TLaZzIL_3mxXRV98ul_nnnu4B6HPlCwooe3xarFZDwtGGK11q7l-hw6oVqbhrTDvay65aqg2dB8dTtOKEKp1az6gfc6lIJSxA3RzEQvkEea_ITaU4C7BhGMq2KdYcljOBXBJuAyAXSyh-d92voQRcHRlzoBTj69_n9ziEPEAbizDR7TXu3GCT4_xCP36-eP29Ly5vDq7OD25bLxQpjQOmGTEKScNp6wXVJmW9Z1X0hDQLV166bwTvFcghHJMSADVLqWWzPme9fwIfd_xruflHXQettJGu87hzuV7m1ywrycxDPZP2lhNlSDGVIKvjwQ5_ZthKnaV5hyrZsskN1Iqo2lF0R3K5zRNGfrnC5TYrQ92ZasPduuD3flQd768lPa88fT4Cvi2A0B90CZAtpMPED10IYMvtkvhDfoHCwmZAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2539557981</pqid></control><display><type>article</type><title>Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kumar, R.K. ; Kaiser, L.M. ; Rockwell, C.E. ; Watts, S.W.</creator><creatorcontrib>Kumar, R.K. ; Kaiser, L.M. ; Rockwell, C.E. ; Watts, S.W.</creatorcontrib><description>Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identified as one of the highly expressed (mRNA) cytokines in the mesenteric PVAT of healthy rats. One report suggested that exogenous IL-10 causes relaxation of mouse mesenteric arteries, also suggesting that IL-10 maybe a potential anti-contractile factor. Hence, we hypothesized that PVAT-derived IL-10 causes vasorelaxation and/or reduces vasoconstriction, thus contributing to the anti-contractile nature of PVAT in health. Mesenteric arteries from rats and mice expressed the receptor for IL-10 (in tunica intima and media) as determined by immunohistochemistry. Mesenteric resistance arteries for rats and superior mesenteric artery for mice were used for isometric contractility studies. Increasing concentrations [0.4–100 ng/mL] of recombinant rat/mouse (rr/mr) IL-10 or vehicle was directly added to half-maximally constricted (phenylephrine, PE) vessels (without PVAT, with endothelium). IL-10 did not cause a direct vasorelaxation. Further, the ability of rrIL-10 to cause a rightward or downward shift of a vasoconstriction-response curve was tested in the rat. The vessels were incubated with rrIL-10 [100 ng/mL or 10 ng/mL] or vehicle for 1.5 h in the tissue bath followed by a cumulative PE [10−8–10−4 M] or U46619 [10−10–10−5 M] response curve. The maximal contractions and EC50 values were similar in IL-10 incubated vessels vs vehicle. Thus, acute exposure of exogenous IL-10 did not reduce local vasoconstriction. To further test if endogenous IL-10 from PVAT was anti-contractile, superior mesenteric arteries from IL-10 WT and KO mice, with and without PVAT, were subjected to increasing concentrations of PE. The anti-contractile nature of PVAT was preserved with both short-term and prolonged depletion (using younger and older mice, respectively) of endogenous IL-10 in males and females. Contrary to our hypothesis, PVAT-derived IL-10 neither caused vasorelaxation nor reduced local vasoconstriction directly/indirectly. Therefore, IL-10 does not contribute to the anti-contractile nature of PVAT in healthy rodents.
[Display omitted]
•IL-10 (mRNA) was expressed in mesenteric PVATs of rats and mice in health.•IL-10 receptor was present in the mesenteric arteries of both rats and mice.•Exogenous IL-10 did not directly vasorelax mesenteric arteries.•IL-10 in PVAT did not reduce vasoconstriction directly or indirectly.•IL-10 does not contribute to the anti-contractile nature of PVAT in health.</description><identifier>ISSN: 1537-1891</identifier><identifier>EISSN: 1879-3649</identifier><identifier>DOI: 10.1016/j.vph.2021.106838</identifier><identifier>PMID: 33540122</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adipocytes ; Adipose tissue ; Adipose Tissue - metabolism ; Animals ; Anti-contractile ; Arteries ; Blood vessels ; Cells, Cultured ; Contractility ; Contraction ; Cytokines ; Depletion ; Endothelium ; Female ; IL-10 ; Immune system ; Immunohistochemistry ; Inflammation ; Interleukin 10 ; Interleukin-10 - genetics ; Interleukin-10 - metabolism ; Interleukin-10 - pharmacology ; Isometric ; Lymphocytes ; Lymphocytes B ; Lymphocytes T ; Macrophages ; Male ; Mesenteric Arteries - drug effects ; Mesenteric Arteries - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; mRNA ; Nitric oxide ; Paracrine Communication ; Perivascular adipose tissue ; Phenylephrine ; Rats ; Rats, Sprague-Dawley ; Receptors, Interleukin-10 - metabolism ; Signal Transduction ; Stromal cells ; Vascular tone ; Vasoconstriction ; Vasoconstriction - drug effects ; Vasodilation ; Vasodilation - drug effects ; Vasorelaxation ; Veins & arteries</subject><ispartof>Vascular pharmacology, 2021-06, Vol.138, p.106838-106838, Article 106838</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Jun 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-ae2520a7a59312f417962fdc7590e861bc5aca43f7e447a245ee76b5852acf2f3</citedby><cites>FETCH-LOGICAL-c479t-ae2520a7a59312f417962fdc7590e861bc5aca43f7e447a245ee76b5852acf2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.vph.2021.106838$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33540122$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, R.K.</creatorcontrib><creatorcontrib>Kaiser, L.M.</creatorcontrib><creatorcontrib>Rockwell, C.E.</creatorcontrib><creatorcontrib>Watts, S.W.</creatorcontrib><title>Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health</title><title>Vascular pharmacology</title><addtitle>Vascul Pharmacol</addtitle><description>Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identified as one of the highly expressed (mRNA) cytokines in the mesenteric PVAT of healthy rats. One report suggested that exogenous IL-10 causes relaxation of mouse mesenteric arteries, also suggesting that IL-10 maybe a potential anti-contractile factor. Hence, we hypothesized that PVAT-derived IL-10 causes vasorelaxation and/or reduces vasoconstriction, thus contributing to the anti-contractile nature of PVAT in health. Mesenteric arteries from rats and mice expressed the receptor for IL-10 (in tunica intima and media) as determined by immunohistochemistry. Mesenteric resistance arteries for rats and superior mesenteric artery for mice were used for isometric contractility studies. Increasing concentrations [0.4–100 ng/mL] of recombinant rat/mouse (rr/mr) IL-10 or vehicle was directly added to half-maximally constricted (phenylephrine, PE) vessels (without PVAT, with endothelium). IL-10 did not cause a direct vasorelaxation. Further, the ability of rrIL-10 to cause a rightward or downward shift of a vasoconstriction-response curve was tested in the rat. The vessels were incubated with rrIL-10 [100 ng/mL or 10 ng/mL] or vehicle for 1.5 h in the tissue bath followed by a cumulative PE [10−8–10−4 M] or U46619 [10−10–10−5 M] response curve. The maximal contractions and EC50 values were similar in IL-10 incubated vessels vs vehicle. Thus, acute exposure of exogenous IL-10 did not reduce local vasoconstriction. To further test if endogenous IL-10 from PVAT was anti-contractile, superior mesenteric arteries from IL-10 WT and KO mice, with and without PVAT, were subjected to increasing concentrations of PE. The anti-contractile nature of PVAT was preserved with both short-term and prolonged depletion (using younger and older mice, respectively) of endogenous IL-10 in males and females. Contrary to our hypothesis, PVAT-derived IL-10 neither caused vasorelaxation nor reduced local vasoconstriction directly/indirectly. Therefore, IL-10 does not contribute to the anti-contractile nature of PVAT in healthy rodents.
[Display omitted]
•IL-10 (mRNA) was expressed in mesenteric PVATs of rats and mice in health.•IL-10 receptor was present in the mesenteric arteries of both rats and mice.•Exogenous IL-10 did not directly vasorelax mesenteric arteries.•IL-10 in PVAT did not reduce vasoconstriction directly or indirectly.•IL-10 does not contribute to the anti-contractile nature of PVAT in health.</description><subject>Adipocytes</subject><subject>Adipose tissue</subject><subject>Adipose Tissue - metabolism</subject><subject>Animals</subject><subject>Anti-contractile</subject><subject>Arteries</subject><subject>Blood vessels</subject><subject>Cells, Cultured</subject><subject>Contractility</subject><subject>Contraction</subject><subject>Cytokines</subject><subject>Depletion</subject><subject>Endothelium</subject><subject>Female</subject><subject>IL-10</subject><subject>Immune system</subject><subject>Immunohistochemistry</subject><subject>Inflammation</subject><subject>Interleukin 10</subject><subject>Interleukin-10 - genetics</subject><subject>Interleukin-10 - metabolism</subject><subject>Interleukin-10 - pharmacology</subject><subject>Isometric</subject><subject>Lymphocytes</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Male</subject><subject>Mesenteric Arteries - drug effects</subject><subject>Mesenteric Arteries - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>mRNA</subject><subject>Nitric oxide</subject><subject>Paracrine Communication</subject><subject>Perivascular adipose tissue</subject><subject>Phenylephrine</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Interleukin-10 - metabolism</subject><subject>Signal Transduction</subject><subject>Stromal cells</subject><subject>Vascular tone</subject><subject>Vasoconstriction</subject><subject>Vasoconstriction - drug effects</subject><subject>Vasodilation</subject><subject>Vasodilation - drug effects</subject><subject>Vasorelaxation</subject><subject>Veins & arteries</subject><issn>1537-1891</issn><issn>1879-3649</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1LHDEUDaVSP9of0JcS6POs-ZwkFAoirQqCgravIZu508l2TLaZzIL_3mxXRV98ul_nnnu4B6HPlCwooe3xarFZDwtGGK11q7l-hw6oVqbhrTDvay65aqg2dB8dTtOKEKp1az6gfc6lIJSxA3RzEQvkEea_ITaU4C7BhGMq2KdYcljOBXBJuAyAXSyh-d92voQRcHRlzoBTj69_n9ziEPEAbizDR7TXu3GCT4_xCP36-eP29Ly5vDq7OD25bLxQpjQOmGTEKScNp6wXVJmW9Z1X0hDQLV166bwTvFcghHJMSADVLqWWzPme9fwIfd_xruflHXQettJGu87hzuV7m1ywrycxDPZP2lhNlSDGVIKvjwQ5_ZthKnaV5hyrZsskN1Iqo2lF0R3K5zRNGfrnC5TYrQ92ZasPduuD3flQd768lPa88fT4Cvi2A0B90CZAtpMPED10IYMvtkvhDfoHCwmZAA</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Kumar, R.K.</creator><creator>Kaiser, L.M.</creator><creator>Rockwell, C.E.</creator><creator>Watts, S.W.</creator><general>Elsevier Inc</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20210601</creationdate><title>Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health</title><author>Kumar, R.K. ; Kaiser, L.M. ; Rockwell, C.E. ; Watts, S.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-ae2520a7a59312f417962fdc7590e861bc5aca43f7e447a245ee76b5852acf2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adipocytes</topic><topic>Adipose tissue</topic><topic>Adipose Tissue - metabolism</topic><topic>Animals</topic><topic>Anti-contractile</topic><topic>Arteries</topic><topic>Blood vessels</topic><topic>Cells, Cultured</topic><topic>Contractility</topic><topic>Contraction</topic><topic>Cytokines</topic><topic>Depletion</topic><topic>Endothelium</topic><topic>Female</topic><topic>IL-10</topic><topic>Immune system</topic><topic>Immunohistochemistry</topic><topic>Inflammation</topic><topic>Interleukin 10</topic><topic>Interleukin-10 - genetics</topic><topic>Interleukin-10 - metabolism</topic><topic>Interleukin-10 - pharmacology</topic><topic>Isometric</topic><topic>Lymphocytes</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Male</topic><topic>Mesenteric Arteries - drug effects</topic><topic>Mesenteric Arteries - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>mRNA</topic><topic>Nitric oxide</topic><topic>Paracrine Communication</topic><topic>Perivascular adipose tissue</topic><topic>Phenylephrine</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Interleukin-10 - metabolism</topic><topic>Signal Transduction</topic><topic>Stromal cells</topic><topic>Vascular tone</topic><topic>Vasoconstriction</topic><topic>Vasoconstriction - drug effects</topic><topic>Vasodilation</topic><topic>Vasodilation - drug effects</topic><topic>Vasorelaxation</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, R.K.</creatorcontrib><creatorcontrib>Kaiser, L.M.</creatorcontrib><creatorcontrib>Rockwell, C.E.</creatorcontrib><creatorcontrib>Watts, S.W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Vascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, R.K.</au><au>Kaiser, L.M.</au><au>Rockwell, C.E.</au><au>Watts, S.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health</atitle><jtitle>Vascular pharmacology</jtitle><addtitle>Vascul Pharmacol</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>138</volume><spage>106838</spage><epage>106838</epage><pages>106838-106838</pages><artnum>106838</artnum><issn>1537-1891</issn><eissn>1879-3649</eissn><abstract>Perivascular adipose tissue (PVAT) is protective and reduces contraction of blood vessels in health. PVAT is composed of adipocytes, multiple types of immune cells and stromal cells. Interleukin (IL)-10, an anti-inflammatory cytokine usually produced by T cells, B cells and macrophages, was identified as one of the highly expressed (mRNA) cytokines in the mesenteric PVAT of healthy rats. One report suggested that exogenous IL-10 causes relaxation of mouse mesenteric arteries, also suggesting that IL-10 maybe a potential anti-contractile factor. Hence, we hypothesized that PVAT-derived IL-10 causes vasorelaxation and/or reduces vasoconstriction, thus contributing to the anti-contractile nature of PVAT in health. Mesenteric arteries from rats and mice expressed the receptor for IL-10 (in tunica intima and media) as determined by immunohistochemistry. Mesenteric resistance arteries for rats and superior mesenteric artery for mice were used for isometric contractility studies. Increasing concentrations [0.4–100 ng/mL] of recombinant rat/mouse (rr/mr) IL-10 or vehicle was directly added to half-maximally constricted (phenylephrine, PE) vessels (without PVAT, with endothelium). IL-10 did not cause a direct vasorelaxation. Further, the ability of rrIL-10 to cause a rightward or downward shift of a vasoconstriction-response curve was tested in the rat. The vessels were incubated with rrIL-10 [100 ng/mL or 10 ng/mL] or vehicle for 1.5 h in the tissue bath followed by a cumulative PE [10−8–10−4 M] or U46619 [10−10–10−5 M] response curve. The maximal contractions and EC50 values were similar in IL-10 incubated vessels vs vehicle. Thus, acute exposure of exogenous IL-10 did not reduce local vasoconstriction. To further test if endogenous IL-10 from PVAT was anti-contractile, superior mesenteric arteries from IL-10 WT and KO mice, with and without PVAT, were subjected to increasing concentrations of PE. The anti-contractile nature of PVAT was preserved with both short-term and prolonged depletion (using younger and older mice, respectively) of endogenous IL-10 in males and females. Contrary to our hypothesis, PVAT-derived IL-10 neither caused vasorelaxation nor reduced local vasoconstriction directly/indirectly. Therefore, IL-10 does not contribute to the anti-contractile nature of PVAT in healthy rodents.
[Display omitted]
•IL-10 (mRNA) was expressed in mesenteric PVATs of rats and mice in health.•IL-10 receptor was present in the mesenteric arteries of both rats and mice.•Exogenous IL-10 did not directly vasorelax mesenteric arteries.•IL-10 in PVAT did not reduce vasoconstriction directly or indirectly.•IL-10 does not contribute to the anti-contractile nature of PVAT in health.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33540122</pmid><doi>10.1016/j.vph.2021.106838</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1537-1891 |
ispartof | Vascular pharmacology, 2021-06, Vol.138, p.106838-106838, Article 106838 |
issn | 1537-1891 1879-3649 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8174099 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adipocytes Adipose tissue Adipose Tissue - metabolism Animals Anti-contractile Arteries Blood vessels Cells, Cultured Contractility Contraction Cytokines Depletion Endothelium Female IL-10 Immune system Immunohistochemistry Inflammation Interleukin 10 Interleukin-10 - genetics Interleukin-10 - metabolism Interleukin-10 - pharmacology Isometric Lymphocytes Lymphocytes B Lymphocytes T Macrophages Male Mesenteric Arteries - drug effects Mesenteric Arteries - metabolism Mice Mice, Inbred C57BL Mice, Knockout mRNA Nitric oxide Paracrine Communication Perivascular adipose tissue Phenylephrine Rats Rats, Sprague-Dawley Receptors, Interleukin-10 - metabolism Signal Transduction Stromal cells Vascular tone Vasoconstriction Vasoconstriction - drug effects Vasodilation Vasodilation - drug effects Vasorelaxation Veins & arteries |
title | Interleukin-10 does not contribute to the anti-contractile nature of PVAT in health |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T00%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-10%20does%20not%20contribute%20to%20the%20anti-contractile%20nature%20of%20PVAT%20in%20health&rft.jtitle=Vascular%20pharmacology&rft.au=Kumar,%20R.K.&rft.date=2021-06-01&rft.volume=138&rft.spage=106838&rft.epage=106838&rft.pages=106838-106838&rft.artnum=106838&rft.issn=1537-1891&rft.eissn=1879-3649&rft_id=info:doi/10.1016/j.vph.2021.106838&rft_dat=%3Cproquest_pubme%3E2539557981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2539557981&rft_id=info:pmid/33540122&rft_els_id=S1537189121000100&rfr_iscdi=true |